Federal Register / Vol. 80, No. 33 / Thursday, February 19, 2015 / Notices 8887 

listed below. This proposed information 

collection was previously published in 

the Federal Register on December 4, 

2014 (Vol. 79, No. 233, pages 72003— 

4) and allowed 60 days for public 

comment. A total of five public 

comments were received. The purpose 

of this notice is to allow an additional 

30 days for public comment. The 

National Cancer Institute (NCI), 

National Institutes of Health, may not 

conduct or sponsor, and the respondent 

is not required to respond to, an 

information collection that has been 

extended, revised, or implemented on or 

after October 1, 1995, unless it displays 

a currently valid OMB control number. 

Direct Comments To OMB: Written 

comments and/or suggestions regarding 

the item(s) contained in this notice, 

especially regarding the estimated 

public burden and associated response 

time, should be directed to the: Office 

of Management and Budget, Office of 

Regulatory Affairs, OIRA_submission@

omb.eop.gov or by fax to 202–395–6974, 

Attention: NIH Desk Officer. 

DATES: Comment Due Date: Comments 

regarding this information collection are 

best assured of having their full effect if 

received within 30-days of the date of 

this publication. 

FOR FURTHER INFORMATION CONTACT: To 

obtain a copy of the data collection 

plans and instruments or request more 

information on the proposed project 

contact: Bradford W. Hesse, Ph.D., 

Health Communication and Informatics 

Research Branch, 9609 Medical Center 

Drive, MSC 9761, Room 3E610, 

Rockville, MD 20850 or call non-toll 

free number 240–276–6721 or Email 

your request, including your address, to 

hesseb@mail.nih.gov. Formal requests 

for additional plans and instruments 

must be requested in writing. 

Proposed Collection: Health 

Information National Trends Survey 

(HINTS) 0925–0538, Reinstatement with 

Change, National Cancer Institute (NCI), 

National Institutes of Health (NIH). 

Need and Use of Information 

Collection: This partnership between 

NCI and FDA will include assessing the 

public’s knowledge of medical devices, 

communications related to product 

recalls, nutritional supplement labeling, 

and topics to inform FDA’s regulatory 

authority over tobacco, such as risk 

perceptions about new tobacco 

products, product pack color gradations, 

perceptions of product harm, and 

tobacco product claims and labels. This 

HINTS survey will couple knowledgerelated questions with inquiries into the 

communication channels through which 

understanding is being obtained, and 

assessment of FDA-regulated material. 

This survey will extend the information 

collected and priorities from HINTS 

which have been to provide a 

comprehensive assessment of the 

American public’s current access to, and 

use of, information about cancer across 

the cancer care continuum from cancer 

prevention, early detection, diagnosis, 

treatment, and survivorship. 

OMB approval is requested for 1 year. 

There are no costs to respondents other 

than their time. The total estimated 

annualized burden hours are 2,159. 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of respondents Number of 

respondents 

Number of 

responses 

per respondent 

Average 

burden per 

response 

(in hours) 

Total annual 

burden hour 

Individuals ........................................................................................................ 4,318 1 30/60 2,159 

Dated: February 9, 2015. 

Karla Bailey, 

NCI Project Clearance Liaison, National 

Institutes of Health. 

[FR Doc. 2015–03382 Filed 2–18–15; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Heart, Lung, and Blood 

Institute; Notice of Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Heart, Lung, 

and Blood Institute Special Emphasis Panel; 

Short-term Educational Experiences in 

Hematology. 

Date: March 11, 2015. 

Time: 8:00 a.m. to 3:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hyatt Regency Bethesda; One 

Bethesda Metro Center; 7400 Wisconsin 

Avenue; Bethesda, MD 20814. 

Contact Person: Melissa E Nagelin, Ph.D.; 

Scientific Review Officer; Office of Scientific 

Review/DERA; National Heart, Lung, and 

Blood Institute; 6701 Rockledge Drive; Room 

7202; Bethesda, MD 20892; 301–435–0297; 

nagelinmh2@nhlbi.nih.gov. 

Name of Committee: National Heart, Lung, 

and Blood Institute Special Emphasis Panel; 

International Strategic Timing of 

Antiretroviral Therapy. 

Date: March 13, 2015. 

Time: 11:00 a.m. to 1:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health; 6705 

Rockledge Drive, Room 7188; Bethesda, MD 

20817; (Telephone Conference Call). 

Contact Person: Chang Sook Kim, Ph.D.; 

Scientific Review Officer; Office of Scientific 

Review/DERA; National Heart, Lung, and 

Blood Institute; 6701 Rockledge Drive; Room 

7188; Bethesda, MD 20892–7924; 301–435– 

0287; carolko@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.233, National Center for 

Sleep Disorders Research; 93.837, Heart and 

Vascular Diseases Research; 93.838, Lung 

Diseases Research; 93.839, Blood Diseases 

and Resources Research, National Institutes 

of Health, HHS). 

Dated: February 12, 2015. 

Michelle Trout, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2015–03344 Filed 2–18–15; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Heart, Lung, and Blood 

Institute; Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 


emcdonald on DSK67QTVN1PROD with NOTICES